APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plasmid DNA CDMO Service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Plasmid DNA CDMO Service Industry Growth and Trends Forecast to 2032

5 June 2026114 pages

Choose your research edition.

Industry ResearchPlasmid DNA CDMO Service Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasmid DNA CDMO Service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Plasmid DNA CDMO Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasmid DNA CDMO Service Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasmid DNA CDMO Service Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

According to APO Research, the global Plasmid DNA CDMO Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Plasmid DNA CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Plasmid DNA CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Plasmid DNA CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Plasmid DNA CDMO Service market include Creative Biogene, AGC Biologics, Biovian, GenScript ProBio, Charles River Laboratories, PackGene, Catalent Biologics, Patheon and Mycenax Biotech Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Plasmid DNA CDMO Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Plasmid DNA CDMO Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Plasmid DNA CDMO Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Plasmid DNA CDMO Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Plasmid DNA CDMO Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Plasmid DNA CDMO Service Market by Company

Creative Biogene

AGC Biologics

Biovian

GenScript ProBio

Charles River Laboratories

PackGene

Catalent Biologics

Patheon

Mycenax Biotech Inc

VGXI

Esco Aster

Eurogentec

53Biologics

SK pharmteco

Cytovance Biologics

Aldevron

Bionova Scientific

Plasmid DNA CDMO Service Segment by Type

Research Grade

Commercial Grade

GMP Grade

Others

Plasmid DNA CDMO Service Segment by Application

Preclinical

Clinical

Commercial

Plasmid DNA CDMO Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasmid DNA CDMO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasmid DNA CDMO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasmid DNA CDMO Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Plasmid DNA CDMO Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Plasmid DNA CDMO Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Plasmid DNA CDMO Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Plasmid DNA CDMO Service Market Share by Region (2021-2026) Table 4. Global Plasmid DNA CDMO Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Plasmid DNA CDMO Service Market Share by Region (2027-2032) Table 6. Global Plasmid DNA CDMO Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Plasmid DNA CDMO Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Plasmid DNA CDMO Service Market Size Share by Type (2021-2026) Table 9. Global Plasmid DNA CDMO Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Plasmid DNA CDMO Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America Plasmid DNA CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Plasmid DNA CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Plasmid DNA CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Plasmid DNA CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Plasmid DNA CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Plasmid DNA CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Plasmid DNA CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Plasmid DNA CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Plasmid DNA CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Plasmid DNA CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Plasmid DNA CDMO Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Plasmid DNA CDMO Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Plasmid DNA CDMO Service Market Size Share by Application (2021-2026) Table 24. Global Plasmid DNA CDMO Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Plasmid DNA CDMO Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America Plasmid DNA CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Plasmid DNA CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Plasmid DNA CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Plasmid DNA CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Plasmid DNA CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Plasmid DNA CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Plasmid DNA CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Plasmid DNA CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Plasmid DNA CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Plasmid DNA CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Plasmid DNA CDMO Service Industry Trends Table 37. Plasmid DNA CDMO Service Industry Drivers Table 38. Plasmid DNA CDMO Service Industry Opportunities and Challenges Table 39. Plasmid DNA CDMO Service Industry Restraints Table 40. Global Plasmid DNA CDMO Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Plasmid DNA CDMO Service Revenue Market Share by Company (2021-2026) Table 42. Global Plasmid DNA CDMO Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Plasmid DNA CDMO Service Key Company Headquarters & Area Served Table 44. Global Plasmid DNA CDMO Service Company, Product Type & Application Table 45. Global Plasmid DNA CDMO Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Plasmid DNA CDMO Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Creative Biogene Company Information Table 49. Creative Biogene Business Overview Table 50. Creative Biogene Plasmid DNA CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Creative Biogene Plasmid DNA CDMO Service Product Portfolio Table 52. Creative Biogene Recent Development Table 53. AGC Biologics Company Information Table 54. AGC Biologics Business Overview Table 55. AGC Biologics Plasmid DNA CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. AGC Biologics Plasmid DNA CDMO Service Product Portfolio Table 57. AGC Biologics Recent Development Table 58. Biovian Company Information Table 59. Biovian Business Overview Table 60. Biovian Plasmid DNA CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Biovian Plasmid DNA CDMO Service Product Portfolio Table 62. Biovian Recent Development Table 63. GenScript ProBio Company Information Table 64. GenScript ProBio Business Overview Table 65. GenScript ProBio Plasmid DNA CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. GenScript ProBio Plasmid DNA CDMO Service Product Portfolio Table 67. GenScript ProBio Recent Development Table 68. Charles River Laboratories Company Information Table 69. Charles River Laboratories Business Overview Table 70. Charles River Laboratories Plasmid DNA CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Charles River Laboratories Plasmid DNA CDMO Service Product Portfolio Table 72. Charles River Laboratories Recent Development Table 73. PackGene Company Information Table 74. PackGene Business Overview Table 75. PackGene Plasmid DNA CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. PackGene Plasmid DNA CDMO Service Product Portfolio Table 77. PackGene Recent Development Table 78. Catalent Biologics Company Information Table 79. Catalent Biologics Business Overview Table 80. Catalent Biologics Plasmid DNA CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Catalent Biologics Plasmid DNA CDMO Service Product Portfolio Table 82. Catalent Biologics Recent Development Table 83. Patheon Company Information Table 84. Patheon Business Overview Table 85. Patheon Plasmid DNA CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Patheon Plasmid DNA CDMO Service Product Portfolio Table 87. Patheon Recent Development Table 88. Mycenax Biotech Inc Company Information Table 89. Mycenax Biotech Inc Business Overview Table 90. Mycenax Biotech Inc Plasmid DNA CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Mycenax Biotech Inc Plasmid DNA CDMO Service Product Portfolio Table 92. Mycenax Biotech Inc Recent Development Table 93. VGXI Company Information Table 94. VGXI Business Overview Table 95. VGXI Plasmid DNA CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. VGXI Plasmid DNA CDMO Service Product Portfolio Table 97. VGXI Recent Development Table 98. Esco Aster Company Information Table 99. Esco Aster Business Overview Table 100. Esco Aster Plasmid DNA CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Esco Aster Plasmid DNA CDMO Service Product Portfolio Table 102. Esco Aster Recent Development Table 103. Eurogentec Company Information Table 104. Eurogentec Business Overview Table 105. Eurogentec Plasmid DNA CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Eurogentec Plasmid DNA CDMO Service Product Portfolio Table 107. Eurogentec Recent Development Table 108. 53Biologics Company Information Table 109. 53Biologics Business Overview Table 110. 53Biologics Plasmid DNA CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. 53Biologics Plasmid DNA CDMO Service Product Portfolio Table 112. 53Biologics Recent Development Table 113. SK pharmteco Company Information Table 114. SK pharmteco Business Overview Table 115. SK pharmteco Plasmid DNA CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. SK pharmteco Plasmid DNA CDMO Service Product Portfolio Table 117. SK pharmteco Recent Development Table 118. Cytovance Biologics Company Information Table 119. Cytovance Biologics Business Overview Table 120. Cytovance Biologics Plasmid DNA CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Cytovance Biologics Plasmid DNA CDMO Service Product Portfolio Table 122. Cytovance Biologics Recent Development Table 123. Aldevron Company Information Table 124. Aldevron Business Overview Table 125. Aldevron Plasmid DNA CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Aldevron Plasmid DNA CDMO Service Product Portfolio Table 127. Aldevron Recent Development Table 128. Bionova Scientific Company Information Table 129. Bionova Scientific Business Overview Table 130. Bionova Scientific Plasmid DNA CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Bionova Scientific Plasmid DNA CDMO Service Product Portfolio Table 132. Bionova Scientific Recent Development Table 133. North America Plasmid DNA CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Plasmid DNA CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Plasmid DNA CDMO Service Market Share by Country (2021-2026) Table 136. North America Plasmid DNA CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Plasmid DNA CDMO Service Market Share Forecast by Country (2027-2032) Table 138. Europe Plasmid DNA CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Plasmid DNA CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Plasmid DNA CDMO Service Market Share by Country (2021-2026) Table 141. Europe Plasmid DNA CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Plasmid DNA CDMO Service Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Plasmid DNA CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Plasmid DNA CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Plasmid DNA CDMO Service Market Share by Country (2021-2026) Table 146. Asia-Pacific Plasmid DNA CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Plasmid DNA CDMO Service Market Share Forecast by Country (2027-2032) Table 148. Latin America Plasmid DNA CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Plasmid DNA CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Plasmid DNA CDMO Service Market Share by Country (2021-2026) Table 151. Latin America Plasmid DNA CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Plasmid DNA CDMO Service Market Share Forecast by Country (2027-2032) Table 153. Middle East & Africa Plasmid DNA CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East & Africa Plasmid DNA CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East & Africa Plasmid DNA CDMO Service Market Share by Country (2021-2026) Table 156. Middle East & Africa Plasmid DNA CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East & Africa Plasmid DNA CDMO Service Market Share Forecast by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Plasmid DNA CDMO Service Product Image Figure 3. Global Plasmid DNA CDMO Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Plasmid DNA CDMO Service Market Size (2021-2032) & (US$ Million) Figure 5. Global Plasmid DNA CDMO Service Market Share by Region: 2025 VS 2032 Figure 6. Global Plasmid DNA CDMO Service Market Share by Region (2021-2032) Figure 7. North America Plasmid DNA CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Plasmid DNA CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Plasmid DNA CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Plasmid DNA CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Plasmid DNA CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Research Grade Image Figure 13. Global Research Grade Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Commercial Grade Image Figure 15. Global Commercial Grade Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. GMP Grade Image Figure 17. Global GMP Grade Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Plasmid DNA CDMO Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Plasmid DNA CDMO Service Market Share by Type 2025 VS 2032 Figure 22. North America Plasmid DNA CDMO Service Market Size Share by Type (2021-2032) Figure 23. Europe Plasmid DNA CDMO Service Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Plasmid DNA CDMO Service Market Size Share by Type (2021-2032) Figure 25. Latin America Plasmid DNA CDMO Service Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Plasmid DNA CDMO Service Market Size Share by Type (2021-2032) Figure 27. Preclinical Image Figure 28. Global Preclinical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Clinical Image Figure 30. Global Clinical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Commercial Image Figure 32. Global Commercial Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Plasmid DNA CDMO Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Plasmid DNA CDMO Service Market Share by Application 2025 VS 2032 Figure 35. North America Plasmid DNA CDMO Service Market Size Share by Application (2021-2032) Figure 36. Europe Plasmid DNA CDMO Service Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Plasmid DNA CDMO Service Market Size Share by Application (2021-2032) Figure 38. Latin America Plasmid DNA CDMO Service Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Plasmid DNA CDMO Service Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Plasmid DNA CDMO Service Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Plasmid DNA CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Plasmid DNA CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Plasmid DNA CDMO Service Market Share by Country (2021-2032) Figure 45. Europe Plasmid DNA CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Plasmid DNA CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Plasmid DNA CDMO Service Market Share by Country (2021-2032) Figure 48. Asia-Pacific Plasmid DNA CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Plasmid DNA CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Plasmid DNA CDMO Service Market Share by Country (2021-2032) Figure 51. Latin America Plasmid DNA CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Plasmid DNA CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Plasmid DNA CDMO Service Market Share by Country (2021-2032) Figure 54. Middle East & Africa Plasmid DNA CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Plasmid DNA CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Plasmid DNA CDMO Service Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Research Grade
  • Commercial Grade
  • GMP Grade
  • Others
Applications
  • Preclinical
  • Clinical
  • Commercial
Companies covered
  • Creative Biogene
  • AGC Biologics
  • Biovian
  • GenScript ProBio
  • Charles River Laboratories
  • PackGene
  • Catalent Biologics
  • Patheon
  • Mycenax Biotech Inc
  • VGXI
  • Esco Aster
  • Eurogentec
  • 53Biologics
  • SK pharmteco
  • Cytovance Biologics
  • Aldevron
  • Bionova Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Plasmid DNA CDMO Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Plasmid DNA CDMO Service Market Size by Region (2021-2032)
  5. 1.4.1 Global Plasmid DNA CDMO Service Market Size by Region (2021-2026)
  6. 1.4.2 Global Plasmid DNA CDMO Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions Plasmid DNA CDMO Service Market Size (2021-2032)
  8. 1.5.1 North America Plasmid DNA CDMO Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Plasmid DNA CDMO Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Plasmid DNA CDMO Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Plasmid DNA CDMO Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Plasmid DNA CDMO Service Market Size Growth Rate (2021-2032)
2 Plasmid DNA CDMO Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Research Grade
  3. 2.1.2 Commercial Grade
  4. 2.1.3 GMP Grade
  5. 2.1.4 Others
  6. 2.2 Global Plasmid DNA CDMO Service Market Size by Type
  7. 2.2.1 Global Plasmid DNA CDMO Service Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Plasmid DNA CDMO Service Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Plasmid DNA CDMO Service Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Plasmid DNA CDMO Service Market Size by Regions
  11. 2.3.1 North America Plasmid DNA CDMO Service Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Plasmid DNA CDMO Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Plasmid DNA CDMO Service Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Plasmid DNA CDMO Service Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Plasmid DNA CDMO Service Market Size Breakdown by Type (2021-2026)
3 Plasmid DNA CDMO Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Preclinical
  3. 3.1.2 Clinical
  4. 3.1.3 Commercial
  5. 3.2 Global Plasmid DNA CDMO Service Market Size by Application
  6. 3.2.1 Global Plasmid DNA CDMO Service Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Plasmid DNA CDMO Service Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Plasmid DNA CDMO Service Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Plasmid DNA CDMO Service Market Size by Regions
  10. 3.3.1 North America Plasmid DNA CDMO Service Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Plasmid DNA CDMO Service Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Plasmid DNA CDMO Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Plasmid DNA CDMO Service Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Plasmid DNA CDMO Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Plasmid DNA CDMO Service Industry Trends
  2. 4.2 Plasmid DNA CDMO Service Industry Drivers
  3. 4.3 Plasmid DNA CDMO Service Industry Opportunities and Challenges
  4. 4.4 Plasmid DNA CDMO Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Plasmid DNA CDMO Service Revenue (2021-2026)
  2. 5.2 Global Plasmid DNA CDMO Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Plasmid DNA CDMO Service Key Company Headquarters & Area Served
  4. 5.4 Global Plasmid DNA CDMO Service Company, Product Type & Application
  5. 5.5 Global Plasmid DNA CDMO Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Plasmid DNA CDMO Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Plasmid DNA CDMO Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Plasmid DNA CDMO Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Creative Biogene
  2. 6.1.1 Creative Biogene Company Information
  3. 6.1.2 Creative Biogene Business Overview
  4. 6.1.3 Creative Biogene Plasmid DNA CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Creative Biogene Plasmid DNA CDMO Service Product Portfolio
  6. 6.1.5 Creative Biogene Recent Developments
  7. 6.2 AGC Biologics
  8. 6.2.1 AGC Biologics Company Information
  9. 6.2.2 AGC Biologics Business Overview
  10. 6.2.3 AGC Biologics Plasmid DNA CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 AGC Biologics Plasmid DNA CDMO Service Product Portfolio
  12. 6.2.5 AGC Biologics Recent Developments
  13. 6.3 Biovian
  14. 6.3.1 Biovian Company Information
  15. 6.3.2 Biovian Business Overview
  16. 6.3.3 Biovian Plasmid DNA CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Biovian Plasmid DNA CDMO Service Product Portfolio
  18. 6.3.5 Biovian Recent Developments
  19. 6.4 GenScript ProBio
  20. 6.4.1 GenScript ProBio Company Information
  21. 6.4.2 GenScript ProBio Business Overview
  22. 6.4.3 GenScript ProBio Plasmid DNA CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 GenScript ProBio Plasmid DNA CDMO Service Product Portfolio
  24. 6.4.5 GenScript ProBio Recent Developments
  25. 6.5 Charles River Laboratories
  26. 6.5.1 Charles River Laboratories Company Information
  27. 6.5.2 Charles River Laboratories Business Overview
  28. 6.5.3 Charles River Laboratories Plasmid DNA CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Charles River Laboratories Plasmid DNA CDMO Service Product Portfolio
  30. 6.5.5 Charles River Laboratories Recent Developments
  31. 6.6 PackGene
  32. 6.6.1 PackGene Company Information
  33. 6.6.2 PackGene Business Overview
  34. 6.6.3 PackGene Plasmid DNA CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 PackGene Plasmid DNA CDMO Service Product Portfolio
  36. 6.6.5 PackGene Recent Developments
  37. 6.7 Catalent Biologics
  38. 6.7.1 Catalent Biologics Company Information
  39. 6.7.2 Catalent Biologics Business Overview
  40. 6.7.3 Catalent Biologics Plasmid DNA CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Catalent Biologics Plasmid DNA CDMO Service Product Portfolio
  42. 6.7.5 Catalent Biologics Recent Developments
  43. 6.8 Patheon
  44. 6.8.1 Patheon Company Information
  45. 6.8.2 Patheon Business Overview
  46. 6.8.3 Patheon Plasmid DNA CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Patheon Plasmid DNA CDMO Service Product Portfolio
  48. 6.8.5 Patheon Recent Developments
  49. 6.9 Mycenax Biotech Inc
  50. 6.9.1 Mycenax Biotech Inc Company Information
  51. 6.9.2 Mycenax Biotech Inc Business Overview
  52. 6.9.3 Mycenax Biotech Inc Plasmid DNA CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Mycenax Biotech Inc Plasmid DNA CDMO Service Product Portfolio
  54. 6.9.5 Mycenax Biotech Inc Recent Developments
  55. 6.10 VGXI
  56. 6.10.1 VGXI Company Information
  57. 6.10.2 VGXI Business Overview
  58. 6.10.3 VGXI Plasmid DNA CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 VGXI Plasmid DNA CDMO Service Product Portfolio
  60. 6.10.5 VGXI Recent Developments
  61. 6.11 Esco Aster
  62. 6.11.1 Esco Aster Company Information
  63. 6.11.2 Esco Aster Business Overview
  64. 6.11.3 Esco Aster Plasmid DNA CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Esco Aster Plasmid DNA CDMO Service Product Portfolio
  66. 6.11.5 Esco Aster Recent Developments
  67. 6.12 Eurogentec
  68. 6.12.1 Eurogentec Company Information
  69. 6.12.2 Eurogentec Business Overview
  70. 6.12.3 Eurogentec Plasmid DNA CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Eurogentec Plasmid DNA CDMO Service Product Portfolio
  72. 6.12.5 Eurogentec Recent Developments
  73. 6.13 53Biologics
  74. 6.13.1 53Biologics Company Information
  75. 6.13.2 53Biologics Business Overview
  76. 6.13.3 53Biologics Plasmid DNA CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 53Biologics Plasmid DNA CDMO Service Product Portfolio
  78. 6.13.5 53Biologics Recent Developments
  79. 6.14 SK pharmteco
  80. 6.14.1 SK pharmteco Company Information
  81. 6.14.2 SK pharmteco Business Overview
  82. 6.14.3 SK pharmteco Plasmid DNA CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 SK pharmteco Plasmid DNA CDMO Service Product Portfolio
  84. 6.14.5 SK pharmteco Recent Developments
  85. 6.15 Cytovance Biologics
  86. 6.15.1 Cytovance Biologics Company Information
  87. 6.15.2 Cytovance Biologics Business Overview
  88. 6.15.3 Cytovance Biologics Plasmid DNA CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Cytovance Biologics Plasmid DNA CDMO Service Product Portfolio
  90. 6.15.5 Cytovance Biologics Recent Developments
  91. 6.16 Aldevron
  92. 6.16.1 Aldevron Company Information
  93. 6.16.2 Aldevron Business Overview
  94. 6.16.3 Aldevron Plasmid DNA CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Aldevron Plasmid DNA CDMO Service Product Portfolio
  96. 6.16.5 Aldevron Recent Developments
  97. 6.17 Bionova Scientific
  98. 6.17.1 Bionova Scientific Company Information
  99. 6.17.2 Bionova Scientific Business Overview
  100. 6.17.3 Bionova Scientific Plasmid DNA CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Bionova Scientific Plasmid DNA CDMO Service Product Portfolio
  102. 6.17.5 Bionova Scientific Recent Developments
7 North America
  1. 7.1 North America Plasmid DNA CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Plasmid DNA CDMO Service Market Size by Country (2021-2026)
  3. 7.3 North America Plasmid DNA CDMO Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Plasmid DNA CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Plasmid DNA CDMO Service Market Size by Country (2021-2026)
  3. 8.3 Europe Plasmid DNA CDMO Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Plasmid DNA CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Plasmid DNA CDMO Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Plasmid DNA CDMO Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Plasmid DNA CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Plasmid DNA CDMO Service Market Size by Country (2021-2026)
  3. 10.3 South America Plasmid DNA CDMO Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Plasmid DNA CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Plasmid DNA CDMO Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Plasmid DNA CDMO Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst